🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 2 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 14/05/2008 | 46,43 | 47,08 | 46,43 | 46,71 | +0,55% | 1,39% | 951.400 |
| 13/05/2008 | 46,36 | 46,93 | 45,95 | 46,46 | -0,11% | 2,11% | 855.000 |
| 12/05/2008 | 45,36 | 46,79 | 44,98 | 46,51 | +3,49% | 3,99% | 1.574.600 |
| 09/05/2008 | 44,74 | 45,12 | 44,44 | 44,94 | -0,99% | 1,51% | 1.123.000 |
| 08/05/2008 | 45,36 | 45,97 | 44,89 | 45,39 | +0,07% | 2,39% | 1.002.400 |
| 07/05/2008 | 46,04 | 46,56 | 45,04 | 45,36 | -1,78% | 3,29% | 808.800 |
| 06/05/2008 | 45,93 | 46,44 | 44,95 | 46,18 | -0,08% | 3,23% | 1.291.400 |
| 05/05/2008 | 45,69 | 46,62 | 45,69 | 46,21 | +1,46% | 2,04% | 1.783.200 |
| 02/05/2008 | 44,50 | 45,56 | 43,63 | 45,55 | +4,35% | 4,35% | 2.232.000 |
| 01/05/2008 | 42,50 | 43,98 | 42,50 | 43,65 | +3,30% | 3,47% | 2.159.800 |
| 30/04/2008 | 43,00 | 43,58 | 41,94 | 42,25 | -1,72% | 3,80% | 780.600 |
| 29/04/2008 | 44,00 | 44,00 | 42,51 | 42,99 | -3,41% | 3,39% | 1.780.400 |
| 28/04/2008 | 43,14 | 44,91 | 43,06 | 44,51 | +2,90% | 4,29% | 1.219.600 |
| 25/04/2008 | 44,09 | 44,61 | 42,63 | 43,26 | -1,68% | 4,48% | 2.675.600 |
| 24/04/2008 | 43,74 | 44,55 | 43,15 | 44,00 | +0,86% | 3,20% | 890.400 |
| 23/04/2008 | 43,06 | 44,40 | 42,58 | 43,62 | +1,23% | 4,23% | 1.285.000 |
| 22/04/2008 | 43,25 | 43,39 | 42,55 | 43,09 | -0,57% | 1,95% | 586.000 |
| 21/04/2008 | 42,60 | 43,48 | 42,45 | 43,34 | +1,77% | 2,42% | 734.000 |
| 18/04/2008 | 42,47 | 42,81 | 42,13 | 42,58 | +0,96% | 1,61% | 1.344.000 |
| 17/04/2008 | 42,27 | 42,49 | 41,13 | 42,18 | -0,01% | 3,22% | 1.219.600 |
| 16/04/2008 | 41,77 | 42,47 | 41,55 | 42,18 | +1,04% | 2,19% | 751.200 |
| 15/04/2008 | 41,62 | 41,85 | 41,17 | 41,75 | +0,78% | 1,63% | 660.000 |
| 14/04/2008 | 42,01 | 42,13 | 41,26 | 41,42 | -1,50% | 2,07% | 923.000 |
| 11/04/2008 | 41,98 | 42,35 | 41,74 | 42,05 | -0,76% | 1,46% | 674.600 |
| 10/04/2008 | 41,19 | 43,05 | 41,19 | 42,37 | +3,14% | 4,53% | 1.089.600 |
| 09/04/2008 | 42,15 | 42,15 | 40,60 | 41,08 | -2,54% | 3,69% | 1.937.200 |
| 08/04/2008 | 42,52 | 42,63 | 42,01 | 42,15 | -1,30% | 1,45% | 462.200 |
| 07/04/2008 | 43,50 | 43,75 | 42,51 | 42,71 | -1,16% | 2,86% | 555.000 |
| 04/04/2008 | 43,60 | 43,86 | 43,14 | 43,21 | -0,62% | 1,65% | 500.200 |
| 03/04/2008 | 43,88 | 44,03 | 42,98 | 43,48 | -1,63% | 2,39% | 1.235.600 |